A prospective double blind placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder pain

被引:24
|
作者
Ainsworth, R.
Dziedzic, K.
Hiller, L.
Daniels, J.
Bruton, A.
Broadfield, J.
机构
[1] Torbay Hosp, Physiotherapy Dept, Torquay TQ2 7AA, England
[2] Univ Birmingham, Sch Hlth Sci, Birmingham B15 2TT, W Midlands, England
[3] Univ Keele, Primary Care Musculoskeletal Res Ctr, Keele ST5 5BG, Staffs, England
[4] Canc Res UK, Clin Trials Unit, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England
[5] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England
[6] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2RR, W Midlands, England
关键词
ultrasound; shoulder pain; physiotherapy; double blind; randomized trial;
D O I
10.1093/rheumatology/kel423
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To compare the effectiveness of manual therapy and ultrasound (US) with manual therapy and placebo ultrasound (placebo US) in the treatment of new episodes of unilateral shoulder pain referred for physiotherapy. Methods. In a multicentre, double blind, placebo-controlled randomized trial, participants were recruited with a clinical diagnosis of unilateral shoulder pain from nine primary care physiotherapy departments in Birmingham, UK. Recruitment took place from January 1999 to September 2001. Participants were 18 yrs old and above. Participants all received advice and home exercises and were randomized to additionally receive manual therapy plus US or manual therapy plus placebo US. The primary outcome measure was the Shoulder Disability Questionnaire (SDQ-UK). Outcomes were assessed at baseline, 2 weeks, 6 weeks and 6 months. Analysis was by intention to treat. Results. A total of 221 participants (mean age 56 yrs) were recruited. 113 participants were randomized to US and 108 to placebo US. There was 76% follow up at 6 weeks and 71% at 6 months. The mean (95% CI) reduction in SDQ scores at 6 weeks was 17 points (13-26) for US and 13 points (9-17) for placebo US (P = 0.06). There were no statistically significant differences at the 5% level in mean changes between groups at any of the time points. Conclusions. The addition of US was not superior to placebo US when used as part of a package of physiotherapy in the short-term management of shoulder pain. This has important implications for physiotherapy practice.
引用
收藏
页码:815 / 820
页数:6
相关论文
共 50 条
  • [31] A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain
    Wallace, MS
    Rowbotham, MC
    Katz, NP
    Dworkin, RH
    Dotson, RM
    Galer, BS
    Rauck, RL
    Backonja, MM
    Quessy, SN
    Meisner, PD
    NEUROLOGY, 2002, 59 (11) : 1694 - 1700
  • [32] A randomized, double-blind, placebo-controlled trial of ormeloxifene in breast pain and nodularity
    Kumar, Sandeep
    Rai, Ruchi
    Agarwal, G. G.
    Dwivedi, Varsha
    Kumar, Surender
    Das, Vinita
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (02): : 69 - 74
  • [33] Ultrasound-Guided BoNT-A (Botulinum Toxin A) Injection Into the Subscapularis for Hemiplegic Shoulder Pain A Randomized, Double-Blind, Placebo-Controlled Trial
    Tan, Botao
    Jia, Lang
    STROKE, 2021, 52 (12) : 3759 - 3767
  • [34] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [35] Peppermint oil (Mintoil®) in the treatment of irritable bowel syndrome:: A prospective double blind placebo-controlled randomized trial
    Cappello, G.
    Spezzaferro, M.
    Grossi, L.
    Manzoli, L.
    Marzio, L.
    DIGESTIVE AND LIVER DISEASE, 2007, 39 (06) : 530 - 536
  • [36] The Effectiveness of Intravenous Parecoxib on the Incidence of Ipsilateral Shoulder Pain After ThOracotomy: A Randomized, Double-Blind, Placebo-Controlled Trial
    Pipanmekaporn, Tanyong
    Punjasawadwong, Yodying
    Charuluxananan, Somrat
    Lapisatepun, Worawut
    Bunburaphong, Pavena
    Boonsri, Settapong
    Tantraworasin, Apichat
    Bunchungmongkol, Nutchanart
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2018, 32 (01) : 302 - 308
  • [37] A Randomized, Double-Blind, Placebo-Controlled Trial of Oral Pregabalin for Relief of Shoulder Pain after Laparoscopic Gynecologic Surgery
    Nutthachote, Pattiya
    Sirayapiwat, Porntip
    Wisawasukmongchol, Wirach
    Charuluxananan, Somrat
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2014, 21 (04) : 669 - 673
  • [38] Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
    Jain, Mamta K.
    De Lemos, James A.
    McGuire, Darren K.
    Ayers, Colby.
    Eitson, Jennifer L.
    Sanchez, Claudia L.
    Kamel, Dena
    Meisner, Jessica A.
    Thomas, Emilia V.
    Hegde, Anita A.
    Mocherla, Satish
    Strebe, Joslyn K.
    Li, Xilong
    Williams, Noelle S.
    Xing, Chao
    Ahmed, Mahmoud S.
    Wang, Ping
    Sadek, Hesham A.
    Schoggins, John W.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
    Pandina, Gahan J.
    Canuso, Carla M.
    Turkoz, Ibrahim
    Kujawa, Mary
    Mahmoud, Ramy A.
    PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (03) : 41 - 57
  • [40] Intrathecal ziconotide in the treatment of chronic nonmalignant pain: A randomized, double-blind, placebo-controlled clinical trial
    Wallace, MS
    Charapata, SG
    Fisher, R
    Byas-Smith, M
    Staats, PS
    Mayo, M
    McGuire, D
    Ellis, D
    NEUROMODULATION, 2006, 9 (02): : 75 - 86